Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Acq. announced
REPLIGEN CORP (RGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 8-K Quarterly results
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
05/02/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/02/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
03/24/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/22/2023 10-K Annual Report for the period ended December 31, 2022
02/22/2023 8-K Quarterly results
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 9.1% stake in REPLIGEN CORP
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.4% stake in Repligen Corp.
02/09/2023 8-K Quarterly results
01/23/2023 SC 13G/A BlackRock Inc. reports a 11% stake in REPLIGEN CORPORATION
11/01/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/01/2022 8-K Quarterly results
09/08/2022 SC 13G BlackRock Inc. reports a 10.2% stake in REPLIGEN CORPORATION
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/02/2022 8-K Quarterly results
Docs: "Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance"
06/01/2022 8-K Quarterly results
04/27/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/27/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance"
04/11/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/11/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/08/2022 8-K Quarterly results
02/17/2022 10-K Annual Report for the period ended December 31, 2021
02/17/2022 8-K Quarterly results
Docs: "Repligen Reports Fourth Quarter and Full Year 2021 Financial Results"
02/14/2022 SC 13G PRICE T ROWE ASSOCIATES INC reports a 5.5% stake in REPLIGEN CORP
02/10/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2022 CT ORDER Form CT ORDER - Confidential treatment order:
01/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/16/2021 8-K Quarterly results
11/05/2021 424B7 Form 424B7 - Prospectus [Rule 424(b)(7)]:
10/28/2021 10-Q Quarterly Report for the period ended September 30, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy